Abstract
An extract (100 mg/kg) of the stem bark of Hintonia standleyana caused a significant decrease in blood glucose levels in both normal and streptozotocin (STZ)-diabetic rats when compared with vehicle-treated groups (p < 0.05). From the active extract, 3-O-β-D-glucopyranosyl-23,24-dihydrocucurbitacin F (1), 5-O-β-D-glucopyranosyl-7-methoxy-3′,4′-dihydroxy-4-phenylcoumarin (2) and 5-O-[β-D-apiofuranosyl-(1→6)-β-D-glucopyranosyl]-7-methoxy-3′,4′-dihydroxy-4-phenylcoumarin (3) were isolated. Coumarin 3 is a new natural product and was identified by spectroscopic methods. Compounds 1 and 3 did not decrease blood glucose levels in normal rats. However, in two different long-term subacute experiments, using animals with a developing diabetes condition and with STZ-induced diabetes, both compounds at daily doses of 10 mg/kg (developing diabetes condition) or 30 mg/kg (STZ-induced diabetes condition) provoked a significant antihyperglycemic activity (p < 0.05). Furthermore, compound 3 restored normal blood glucose levels in STZ-induced diabetic rats. In all cases, the groups treated with the active principles and the extract showed less body weight lost than the glibenclamide-treated and diabetic control groups (p < 0.05). These results showed that the antihyperglycemic active principles of H. standleyana are both 4-phenylcoumarins and cucurbitacin glycosides.
Key words
Hintonia standleyana
- Rubiaceae - 4-phenylcoumarins - cucurbitacins; 3-O-β-D-glucopyranosyl-23,24-dihydrocucurbitacin F - 5-O-[β-D-apiofuranosyl-(1→6)-β-D-glucopyranosyl]-7-methoxy-3′,4′-dihydroxy-4-phenylcoumarin - antihyperglycemic
References
-
1
Burke J P, Williams K, Narayan K MV, Leibson C, Haffner S M, Stern M P.
A population perspective on diabetes prevention: whom should we target for preventing weight gain?.
Diabetes Care.
2003;
26
1999-2004
-
2
Kecskemeti V, Bagi Z, Pacher P, Posa I, Kocsis , Koltai M Z.
New trends in the development of oral antidiabetic drugs.
Curr Med Chem.
2002;
9
53-71
-
3
Marles R J, Farnsworth N R.
Antidiabetic plants and their active constituents.
Phytomedicine.
1995;
2
137-89
-
4
Subash-Babu P, Mainzen-Prince P S.
Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocin-induced diabetic rats.
J Pharm Pharmacol.
2004;
56
1435-42
-
5
Landa E.
Anales del Instituto Medico Nacional.
Mexico.
1913;
12
146
-
6
Terres J.
Anales del Instituto Medico Nacional.
Mexico.
1913;
12
109
-
7 Martinez M. Las Plantas Medicinales de Mexico. 6ª Ed Mexico; Ediciones Botas 1989: pp 85-7
-
8 Kaiser H, Geyer H. Zur Pharmakognosie der Rinde von Coutareae latiflora D. C. Arch Pharm 1955: 535 (Chemie); 595 (Pharmakolgie)
-
9
Korec R; Heinz-Sensch K, Zoukas T.
Effects of the neoflavonoid coutareagenin, one of the antidiabetic active substances of Hintonia latiflora, on streptozotocin-induced diabetes mellitus in rats.
Drug Research.
2000;
50
122-8
-
10
Slijepcevic M, Kraus L.
Diabetische Mäuse als Prüfmodell für hypoglykämische Aktivitäten von Pflanzenextrakten und Insulinpräparaten.
Acta Ther.
1997;
23
47
-
11
Khur R.
Orale Diabetestherapie mit einem Euphorbiaceenextrakt.
Landarzt.
1953;
29
1
-
12 Bastien M. Recherches sur les copalchis, drogues hypoglycémiantes et en particulier sur le Coutarea latiflora DC (Rubiaceae). Dissertation. Faculté de Pharmacie de l’Université Paris 1961
-
13
Pinto A, Capasso A, Sorrentino L.
Experimental animal studies on the hypoglycemic effects of a copalchi extract.
Drug Research.
1997;
47
829-33
-
14 Schimd P. Bericht über die Behandlung mit dem peroralen Antidiabetikum Sucontral®
. Konstanz; Sonderdruck 1951
-
15
Mata R, Camacho M, Cervera E, Bye R, Linares E.
Secondary metabolites from Hintonia latiflora
.
Phytochemistry.
1990;
29
2037-40
-
16
Mata R, Calzada F, Garcia M.
Chemical studies on Mexican plants used in traditional medicine, VI: Additional new 4-phenylcoumarins from Exostema caribeaum
.
J Nat Prod.
1988;
51
851-6
-
17
Mata R, Calzada F, Garcia M, Reguero M.
Chemical studies on Mexican plants used in traditional medicine, III: New 4-phenylcoumarins from Exostema caribeaum
.
J Nat Prod.
1987;
50
866-70
-
18
Reher G, Kraus L.
New neoflavonoids from Coutarea latiflora
.
J Nat Prod.
1984;
47
172-4
-
19 González Chévez L, Hersch Martínez P, Juárez Miranda A, Pérez Cardona A. Plantas Medicinales de Copalillo y Temalac, Guerrero, Serie Patrimonio Vivo 5. Mexico; Actores Sociales de la Flora Medicinal en México 2000: pp 27-8
-
20
Reguero M, Mata R, Bye R, Linares E, Delgado G.
Chemical studies on Mexican plants used in traditional medicine, II: Curcubitacins from Hintonia latiflora
.
J Nat Prod.
1987;
50
315-6
-
21
Mata R, Camacho M, Mendoza S, Cruz M C.
A phenylstyrene from Hintonia latiflora
.
Phytochemistry.
1992;
31
3199-201
-
22
Mata R, Albor C, Pereda-Miranda R, McLaughlin J L.
Cytotoxic constituents of Exostema mexicanum
.
Planta Med.
1990;
56
241
-
23 Bullock A. A. Hooker’s Icones Plantarum, Tabula 3295. London; 1935: pp 1-8
-
24
Verspohl E J.
Recommended testing in diabetes research.
Planta Med.
2002;
68
581-90
-
25
Sharma S R, Dwivedi S K, Swarup D.
Hypoglyceamic antihyperglicaemic and hypolipidemic activities of Caesalpinia bonducella seeds in rats.
J Ethnopharmacol.
1997;
58
39-44
-
26
Aquino R, D’Agostino M, De Simone F, Pizza C.
4-Arylcoumarin glycosides from Coutarea hexandra
.
Phytochemistry.
1988;
27
1827-30
-
27
Virdi J, Sivakami S, Shahani S, Suthar A C, Banavalikar M M, Biyani M K.
Antihyperglycemic effects of three extracts from Momordica charantia
.
J Ethnopharmacol.
2003;
88
107-11
-
28
Perez R M, Zavala M A, Perez S, Perez C.
Antidiabetic effect of compounds isolated from plants.
Phytomedicine.
1998;
5
55-75
-
29
Alarcon-Aguilar F J, Hernandez-Galicia E, Campos-Sepulveda A E, Xolalpa-Molina S, Rivas-Vilchis J F, Vazquez-Carrillo L I. et al .
et alEvaluation of the hypoglycemic effect of Cucurbita ficifolia Bouché (Cucurbitaceae) in different experimental models.
J Ethnopharmacol.
2002;
82
185-9
-
30
Diatewa M, Badila-Samba C, Hondi-Assah C H, Abena A A.
Hypoglycemic and antihyperglycemic effects of diethyl ether fraction isolated from the aqueous extract of the leaves of Cogniauxia podoleana in normal and alloxan-induced diabetic rats.
J Ethnopharmacol.
2004;
92
229-32
Dr. Rachel Mata
Facultad de Química
Universidad Nacional Autónoma de México
Coyoacán 04510
México City
México
Phone: +52-5-5622-5289
Fax: +52-5-5622-5329
Email: rachel@servidor.unam.mx
